Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Integra Lifesciences Holdings Corp shares valued at $25,701 were sold by Mosebrook Jeffrey on Aug 19 ’24. At $21.58 per share, Mosebrook Jeffrey sold 1,191 shares. The insider’s holdings dropped to 36,088 shares worth approximately $0.63 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ESSIG STUART purchased 52,641 shares, netting a total of over 1,499,979 in proceeds. Following the buying of shares at $28.49 each, the insider now holds 487,922 shares.
Before that, HILL BARBARA B had added 36,350 shares to its account. In a trade valued at $995,816, the Director bought Integra Lifesciences Holdings Corp shares for $27.40 each. Upon closing the transaction, the insider’s holdings increased to 36,350 shares, worth approximately $0.63 million.
As published in a research note from Citigroup on July 30, 2024, Integra Lifesciences Holdings Corp [IART] has been rated down from a Neutral to a Sell and the price target has been revised to $23 from $30. Analysts at BTIG Research downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in late July. As of May 07, 2024, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for IART. Earlier on May 07, 2024, Oppenheimer downgraded its rating. Their new recommendation was “a Perform” for IART stock which previously was a “an Outperform”.
Analyzing IART Stock Performance
During the last five days, there has been a surge of approximately 1.05%. Over the course of the year, Integra Lifesciences Holdings Corp shares have dropped approximately -60.23%. Shares of the company reached a 52-week high of $45.42 on 02/20/24 and a 52-week low of $16.96 on 09/11/24. A 50-day SMA is recorded $20.72, while a 200-day SMA reached $31.32. Nevertheless, trading volume fell to 0.79 million shares from 0.62 million shares the previous day.
Support And Resistance Levels for Integra Lifesciences Holdings Corp (IART)
According to the 24-hour chart, there is a support level at 17.11, which, if violated, would cause prices to drop to 16.91. In the upper region, resistance lies at 17.51. The next price resistance is at 17.71. RSI (Relative Strength Index) is 35.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.15, which suggests the price will decrease in the coming days. Percent R is at 75.74%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
